MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Alterations in gut microbiota composition in VPS35 associated PARK17 mouse model

TH. Yeh, SP. Tsao, HY. Huang, CC. Chiu (Taipei, Taiwan)

Meeting: 2025 International Congress

Keywords: Neurogenesis, Parkinson’s

Category: Parkinson's Disease: Etiology (non-genetics)

Objective: This study explores whether host genetics such as specific VPS35 genetic variations linked to PD can shape the gut microbiome.

Background: Heterozygous (D620N) mutation of vacuolar protein sorting 35 (VPS35) is genetic cause of PARK17. Recent research underscores the role of gut microbial dysbiosis in the development of PD; however, the link between genetic change and gut microbiota dysbiosis remain poorly understood.

Method: PARK17 has been modeled by heterozygous VPS35(D620N/+) knockin mouse in our group, exhibiting late-onset pathological and behavioral phenotypes of PD. Gut microbiota composition was analyzed by 16S rRNA gene sequencing and data analysis.

Results: We observed significant neurodegeneration in 18-month-old VPS35(D620N/+) knockin mice, with a greater than 70% reduction in TH-positive dopaminergic neurons in the SNpc compared to 12-week-old wild-type C57BL/6J controls, which were accompanied by severe motor deficits, including a 50% reduction in rotarod performance and a 60% increase in pole test descent time. 16S rRNA gene sequencing of fecal samples revealed significant alteration of gut microbiota composition in the PD group compared to WT controls. While α-diversity, representing species richness and evenness, remained similar across groups, β-diversity metrics, including Bray-Curtis dissimilarity and UniFrac distances, indicated distinct microbial community structures between the groups. Both groups were predominantly composed of the bacterial phyla Firmicutes, Bacteroidetes, Proteobacteria, TM7, and Deferribacteres; however, at the genus level, the PD group exhibited higher abundances of Odoribacter, Candidatus Arthromitus, Prevotella, Flexispira, and Anaeroplasma, while the control group was enriched in Coprococcus, Allobaculum, and Anaerostipes.

Conclusion: These findings suggest that PARK17 associated VPS35 genetic variation can cause dysbiosis of gut microbiota.

To cite this abstract in AMA style:

TH. Yeh, SP. Tsao, HY. Huang, CC. Chiu. Alterations in gut microbiota composition in VPS35 associated PARK17 mouse model [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/alterations-in-gut-microbiota-composition-in-vps35-associated-park17-mouse-model/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/alterations-in-gut-microbiota-composition-in-vps35-associated-park17-mouse-model/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley